BYOOVIZ

Formula & Concentration

BYOOVIZ- ranibizumab-nuna injection, solution

Manufacturer

Biogen

Indications

BYOOVIZ, a vascular endothelial growth factor (VEGF) inhibitor, is indicated for the treatment of patients with:

Neovascular (Wet) Age-Related Macular Degeneration (AMD)

Macular Edema Following Retinal Vein Occlusion (RVO)

Myopic Choroidal Neovascularization (mCNV)

Product Options

Package Size

NDC #

Presentation

0.05 ml

64406-0019-01

Vial

Shelf Life and Storage

BYOOVIZ should be refrigerated at 2°C to 8°C (36°F to 46°F). DO NOT FREEZE. Do not use beyond the date stamped on the label. Protect BYOOVIZ vials from light and store in the original carton until time of use.  Prior to use, the unopened vial can be stored at temperatures up to 86°F (30°C) for up to 72 hours.